Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-25

Clinical Trial Update: Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency

View source ↗

Summary

A retrospective study evaluated compassionate-use hydroxychloroquine sulfate in patients with Lipin-1 deficiency, focusing on safety and rhabdomyolysis-related …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: LIPIN1 Deficiency | Status: WITHDRAWN